Evidence map›Paper›PMID 29214368›Full record

ArticleInternational journal of clinical pharmacy2018

Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients.

Saurav Ghimire, Colin Banks, Matthew D Jose, Ronald L Castelino, Syed Tabish R Zaidi

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saurav GhimireUnit for Medication Outcomes Research and Education (UMORE), Pharmacy, School of Medicine, Faculty of Health, University of Tasmania, Hobart, 7001, Australia.
Colin BanksDepartment of Nephrology, Royal Hobart Hospital, Hobart, Australia.
Matthew D JoseDepartment of Nephrology, Royal Hobart Hospital, Hobart, Australia.
Ronald L CastelinoUnit for Medication Outcomes Research and Education (UMORE), Pharmacy, School of Medicine, Faculty of Health, University of Tasmania, Hobart, 7001, Australia.
Syed Tabish R ZaidiUnit for Medication Outcomes Research and Education (UMORE), Pharmacy, School of Medicine, Faculty of Health, University of Tasmania, Hobart, 7001, Australia. tabish.razizaidi@utas.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Medication nonadherence is a major problem in chronic kidney failure patients undergoing dialysis. Pharmacists play a vital role in improving medication-related patient outcomes, reducing drug-related problems, and improving medication adherence. However, little is known about how pharmacists assess medication adherence in dialysis patients. Objective To measure pharmacists' perceptions, current practices, and barriers to assessing adherence in dialysis patients. Setting Australian renal-specialised pharmacists. Method An online survey was conducted between March and May 2016. Survey included five psychometric scales measuring perceived prevalence, contributors, effective methods, barriers, and confidence to assess adherence on a 10-point Likert scale (1 = strongly disagree; 10 = strongly agree). Current practices were identified using a 4-point graded response (1 = do not practice; 4 = practice for all).

main outcome measurePerception scores, scale reliability, and responses to current practices questionnaire. Results 41 pharmacists completed the survey (response rate, 91.1%). The majority (91.9%, n = 34; median = 8.0) agreed patients were nonadherent to medication. Time constraints (43.8%, n = 14) and hospital support (31.3%, n = 10) were perceived as barriers to assessment. Objective blood monitoring was frequently used to determine nonadherence (57.1%, n = 16), whereas subjective interviews were rarely conducted (27.6%, n = 8). Though all pharmacists support the presence of dedicated pharmacist for assessing adherence (100.0%, n = 33), only 24.2% were actually performing this function. Conclusion Pharmacists were rarely assigned for adherence assessment in dialysis settings. Established self-report methods were under-utilised compared to objective methods. Future research should investigate the effectiveness of pharmacists' involvement in facilitating adherence promotion and early identification of medication-related issues in dialysis patients.

Indexed as

Attitude of Health PersonnelAdultCross-Sectional StudiesFemaleHumansMaleMedication AdherenceMiddle AgedPharmacistsProfessional RoleRenal DialysisAustraliaDialysisKidney failure, chronicMedication adherenceRenal pharmacists

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.